Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA  ) will host a live audio webcast at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas, NV. Jon Congleton, Senior Vice President and General Manager, Global CNS will present on Wednesday, May 15, 2013.

What:

  Teva Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference

Who:

Jon Congleton, Senior Vice President and General Manager, Global CNS, Teva Pharmaceutical Industries Ltd.

When:

Wednesday, May 15, 2013 at 2:20 PM (PT)

Where:

www.tevapharm.com

How:

Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA  ) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $20.3 billion in net revenues in 2012.



IR:
Kevin C. Mannix
United States
215-591-8912
Tomer Amitai
Israel
972 (3) 926-7656
PR:
Iris Beck Codner
Israel
972 (3) 926-7246
Denise Bradley
United States
215-591-8974

KEYWORDS:   United States  North America  Nevada  Middle East  Israel

INDUSTRY KEYWORDS:

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2429391, ~/Articles/ArticleHandler.aspx, 12/22/2014 5:03:17 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...